Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Journal of Molecular Biology
|
June 17, 2009
Conformational adaptability of Redbeta during DNA annealing and implications for its structural relationship with Rad52
Axel Erler, Susanne Wegmann, Celine Elie-Caille, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
January 14, 2021
Extensive transcription mis-regulation and membrane defects in AdipoR2-deficient cells challenged with saturated fatty acids
Mario Ruiz, Henrik Palmgren, Marcus Henricsson, et al.
Oncotarget
|
May 17, 2018
Functional significance of co-occurring mutations in <i>PIK3CA</i> and <i>MAP3K1</i> in breast cancer
Alvaro Avivar-Valderas, Robert McEwen, Amir Taheri-Ghahfarokhi, et al.
BMC Biology
|
December 30, 2018
BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3B
Matthew A Coelho, Songyuan Li, Luna Simona Pane, et al.
Nature Communications
|
May 9, 2025
Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems
Louis C Dacquay, Panagiotis Antoniou, Astrid Mentani, et al.
Blood
|
August 26, 2025
A prime editing strategy to rewrite the γ-globin promoters and reactivate fetal hemoglobin for sickle cell disease
Anne Chalumeau, Maria Bou Dames, Letizia Fontana, et al.
Nature Communications
|
November 7, 2024
Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles
Dmitrii Degtev, Jack Bravo, Aikaterini Emmanouilidi, et al.
Kidney International
|
August 4, 2018
A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell-derived kidney model for drug discovery
Cecilia Boreström, Anna Jonebring, Jing Guo, et al.
Nucleic Acids Research
|
July 23, 2018
Decoding non-random mutational signatures at Cas9 targeted sites
Amir Taheri-Ghahfarokhi, Benjamin J M Taylor, Roberto Nitsch, et al.
Ebiomedicine
|
March 4, 2018
Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype
Mikael Bjursell, Michelle J Porritt, Elke Ericson, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Journal of Molecular Biology
|
June 17, 2009
Conformational adaptability of Redbeta during DNA annealing and implications for its structural relationship with Rad52
Axel Erler, Susanne Wegmann, Celine Elie-Caille, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
January 14, 2021
Extensive transcription mis-regulation and membrane defects in AdipoR2-deficient cells challenged with saturated fatty acids
Mario Ruiz, Henrik Palmgren, Marcus Henricsson, et al.
Oncotarget
|
May 17, 2018
Functional significance of co-occurring mutations in <i>PIK3CA</i> and <i>MAP3K1</i> in breast cancer
Alvaro Avivar-Valderas, Robert McEwen, Amir Taheri-Ghahfarokhi, et al.
BMC Biology
|
December 30, 2018
BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3B
Matthew A Coelho, Songyuan Li, Luna Simona Pane, et al.
Nature Communications
|
May 9, 2025
Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems
Louis C Dacquay, Panagiotis Antoniou, Astrid Mentani, et al.
Blood
|
August 26, 2025
A prime editing strategy to rewrite the γ-globin promoters and reactivate fetal hemoglobin for sickle cell disease
Anne Chalumeau, Maria Bou Dames, Letizia Fontana, et al.
Nature Communications
|
November 7, 2024
Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles
Dmitrii Degtev, Jack Bravo, Aikaterini Emmanouilidi, et al.
Kidney International
|
August 4, 2018
A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell-derived kidney model for drug discovery
Cecilia Boreström, Anna Jonebring, Jing Guo, et al.
Nucleic Acids Research
|
July 23, 2018
Decoding non-random mutational signatures at Cas9 targeted sites
Amir Taheri-Ghahfarokhi, Benjamin J M Taylor, Roberto Nitsch, et al.
Ebiomedicine
|
March 4, 2018
Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype
Mikael Bjursell, Michelle J Porritt, Elke Ericson, et al.
Page
of 5